School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Georgia Chen PhD

  • Department of Hematology and Medical Oncology
    Professor Emeritus
  • (404) 778-3977
  • gzchen@emory.edu
Head shot of Georgia Chen

Overview

A Georgia Cancer Coalition Distinguished Cancer Scholar, Georgia Chen, PhD, is Professor Emeritus in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Chen is a well-trained molecular oncologist with experience in the molecular analyses of oncogene expression, gene regulation, cellular signal transduction, and using animal models for lung and head and neck cancer.

Academic Appointment

  • Professor, Emory University School of Medicine
  • Visiting Professor, Tianjin Medical University
  • Visiting Professor, Central South University Xiangya School of Medicine

Education

Degrees

  • PhD from Louisiana State University
  • BS from Beijing Institute of Chemical Technology

Research

Focus

  • Head and neck cancer and lung cancer accounts for 25% of all cancer related deaths in the United States. Over the last 20 years, my research has focused and will continue to focus on: a. Identification of metastasis-related genes and proteins in lung and head and neck cancer.b. Study of signal transduction pathways in lung and head and neck cancer. c.Development of prognosis or therapeutic biomarkers of cancer. d.Chemoprevention of lung and head and neck cancer. e.Development of anticancer therapeutic drugs.

Publications

  • Correction: Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    PLoS One Volume: 19 Page(s): e0308819
    01/01/2024 Authors: Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M
  • Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
    Nat Med Volume: 29 Page(s): 880 - 887
    04/01/2023 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
  • The diverse functions of FAT1 in cancer progression: good, bad, or ugly?
    J Exp Clin Cancer Res Volume: 41 Page(s): 248
    08/15/2022 Authors: Chen ZG; Saba NF; Teng Y
  • Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
    Oncologist Volume: 27 Page(s): 48 - 56
    02/03/2022 Authors: Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C
  • Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC).
    Oral Oncol Volume: 122 Page(s): 105546
    11/01/2021 Authors: Shu L; Wang D; Nannapaneni S; Sun Y; Griffith CC; Wang X; Chen Z; Patel M; El-Deiry M; Shin DM
  • Defining HPV-specific B cell responses in patients with head and neck cancer.
    Nature Volume: 597 Page(s): 274 - 278
    09/01/2021 Authors: Wieland A; Patel MR; Cardenas MA; Eberhardt CS; Hudson WH; Obeng RC; Griffith CC; Wang X; Chen ZG; Kissick HT
  • The Proteomic Landscape of Growth Factor Signaling Networks Associated with FAT1 Mutations in Head and Neck Cancers.
    Cancer Res Volume: 81 Page(s): 4402 - 4416
    09/01/2021 Authors: Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
  • Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer.
    Nature Volume: 597 Page(s): 279 - 284
    09/01/2021 Authors: Eberhardt CS; Kissick HT; Patel MR; Cardenas MA; Prokhnevska N; Obeng RC; Nasti TH; Griffith CC; Im SJ; Wang X
  • Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1.
    Nat Commun Volume: 12 Page(s): 4960
    08/16/2021 Authors: Pan C; Kang J; Hwang JS; Li J; Boese AC; Wang X; Yang L; Boggon TJ; Chen GZ; Saba NF
  • Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth invivo in head and neck cancer models.
    Oncol Rep Volume: 45
    05/01/2021 Authors: Amin ARMR; Wang D; Nannapaneni S; Lamichhane R; Chen ZG; Shin DM
  • Combinatorial approaches targeting the EGFR family and c-Met in SCCHN.
    Oral Oncol Volume: 112 Page(s): 105074
    01/01/2021 Authors: Wang D; Lu Y; Nannapaneni S; Griffith CC; Steuer C; Qian G; Wang X; Chen Z; Patel M; El-Deiry M
  • Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    PLoS One Volume: 16 Page(s): e0247498
    01/01/2021 Authors: Nannapaneni S; Griffith CC; Magliocca KR; Chen W; Lyu X; Chen Z; Wang D; Wang X; Shin DM; Chen ZG
  • Editor's Note: The Pivotal Role of Integrin 1 in Metastasis of Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res Volume: 26 Page(s): 5052
    09/15/2020 Authors: Wang D; Mller S; Ruhul Amin ARM; Huang D; Su L; Hu Z; Rahman MA; Nannapaneni S; Koenig L; Chen Z
  • Corrigendum: Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.
    Angew Chem Int Ed Engl Volume: 59 Page(s): 12575
    07/27/2020 Authors: Rahman MA; Wang P; Zhao Z; Wang D; Nannapaneni S; Zhang C; Chen Z; Griffith CC; Hurwitz SJ; Chen ZG
  • Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer.
    Vaccines (Basel) Volume: 8
    04/14/2020 Authors: Bommireddy R; Munoz LE; Kumari A; Huang L; Fan Y; Monterroza L; Pack CD; Ramachandiran S; Reddy SJC; Kim J
  • A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting.
    Mol Cancer Ther Volume: 19 Page(s): 999 - 1007
    04/01/2020 Authors: Shu L; Wang D; Saba NF; Chen ZG
  • Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    PLoS One Volume: 15 Page(s): e0238497
    01/01/2020 Authors: Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M
  • Histopathology Feature Mining and Association with Hyperspectral Imaging for the Detection of Squamous Neoplasia.
    Sci Rep Volume: 9 Page(s): 17863
    11/28/2019 Authors: Lu G; Wang D; Qin X; Muller S; Little JV; Wang X; Chen AY; Chen G; Fei B
  • Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance.
    Mol Cancer Ther Volume: 18 Page(s): 1909 - 1915
    11/01/2019 Authors: Saba NF; Chen ZG; Haigentz M; Bossi P; Rinaldo A; Rodrigo JP; Mkitie AA; Takes RP; Strojan P; Vermorken JB
  • Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.
    Head Neck Pathol Volume: 13 Page(s): 304 - 312
    09/01/2019 Authors: Lesinski GB; Nannapaneni S; Griffith CC; Patel M; Chen W; Chen Z; Ahmed R; Wieland A; Shin DM; Chen ZG
  • Hypofractionated Radiation for Benign Meningiomas and Vestibular Schwannomas
    Volume: 105 Page(s): E97 - E97
    09/01/2019 Authors: Dhere VR; Sudmeier LJ; Buchwald ZS; Tian S; Jiang X; Zhang C; Chen Z; Eaton BR; Shu HKG; Crocker IR
  • Reduced Lung Dose is Associated with Decreased Incidence of Pulmonary Toxicity after Total Body Irradiation in Pediatric Patients
    Volume: 105 Page(s): S189 - S189
    09/01/2019 Authors: Sudmeier LJ; Abugideiri M; Tian S; Goyal S; Chen Z; Eaton BR; Khan MK; Esiashvili N
  • Effective treatment of squamous cell carcinoma of the head and neck (HNSCC) using a combined regimen of tipifarnib and cetuximab
    Volume: 79
    07/01/2019 Authors: Shu L; Wang D; Nannapaneni S; Shin DM; Saba NF; Chen GZ
  • Factors associated with metastatic presentation in HPV-related squamous cell carcinoma of the head and neck (SCCHN): A National Cancer Database (NCDB) analysis.
    Volume: 37
    05/20/2019 Authors: Bean MB; Switchenko JM; Steuer CE; Patel M; El-Deiry M; Higgins KA; McDonald MW; Chen ZG; Beitler JJ; Shin DM
  • Phase 1b study of chemoprevention with green tea polyphenon E (PPE) and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (Erlotinib) in patients (pts) with advanced premalignant (AP) lesions of the head and neck.
    Volume: 37
    05/20/2019 Authors: Shin DM; Beitler JJ; El-Deiry M; Steuer CE; Chen AY; Baddour HM; Chen ZG; Roser S; Magliocca KR; Patel M
  • Comparison of the seventh and eighth editions of the American Joint Committee on Cancer (AJCC) staging for oropharyngeal squamous cell carcinomas (OPSCC): A Surveillance, Epidemiology and End Results Program (SEER) database analysis.
    Volume: 37
    05/20/2019 Authors: Trivedi S; Song H; Liu Y; Steuer CE; Stokes W; Kaka A; Patel M; Chen ZG; Shin DM; Aiken A
  • Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.
    J Clin Invest Volume: 129 Page(s): 2431 - 2445
    05/13/2019 Authors: Pan C; Jin L; Wang X; Li Y; Chun J; Boese AC; Li D; Kang H-B; Zhang G; Zhou L
  • TUMOR ASSOCIATED MACROPHAGE DYNAMICS IN PEDIATRIC HIGH-GRADE. GLIOMAS
    Volume: 21 Page(s): 123 - 123
    04/01/2019 Authors: Ross J; Chen Z; Szulzewsky F; Monterroza L; Schniederjan M; Becher O; Hambardzumyan D
  • A continuous-flow acoustofluidic cytometer for single-cell mechanotyping.
    Lab Chip Volume: 19 Page(s): 387 - 393
    01/29/2019 Authors: Wang H; Liu Z; Shin DM; Chen ZG; Cho Y; Kim Y-J; Han A
  • Adaptive deep learning for head and neck cancer detection using hyperspectral imaging.
    Vis Comput Ind Biomed Art Volume: 2 Page(s): 18
    01/01/2019 Authors: Ma L; Lu G; Wang D; Qin X; Chen ZG; Fei B
  • MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.
    Cancer Cell Volume: 34 Page(s): 315 - 330.e7
    08/13/2018 Authors: Jin L; Chun J; Pan C; Li D; Lin R; Alesi GN; Wang X; Kang H-B; Song L; Wang D
  • Detection and delineation of squamous neoplasia with hyperspectral imaging in a mouse model of tongue carcinogenesis.
    J Biophotonics Volume: 11
    03/01/2018 Authors: Lu G; Wang D; Qin X; Muller S; Wang X; Chen AY; Chen ZG; Fei B
  • A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma.
    Mol Cancer Ther Volume: 17 Page(s): 710 - 716
    03/01/2018 Authors: Steuer CE; Griffith CC; Nannapaneni S; Patel MR; Liu Y; Magliocca KR; El-Deiry MW; Cohen C; Owonikoko TK; Shin DM
  • Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells.
    J Am Chem Soc Volume: 140 Page(s): 2478 - 2484
    02/21/2018 Authors: Wang P; Rahman MA; Zhao Z; Weiss K; Zhang C; Chen Z; Hurwitz SJ; Chen ZG; Shin DM; Ke Y
  • Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.
    Clin Cancer Res Volume: 24 Page(s): 858 - 869
    02/15/2018 Authors: Wang X; Beitler JJ; Huang W; Chen G; Qian G; Magliocca K; Patel MR; Chen AY; Zhang J; Nannapaneni S
  • Deformable Registration of Histological Cancer Margins to Gross Hyperspectral Images using Demons.
    Proc SPIE Int Soc Opt Eng Volume: 10581
    02/01/2018 Authors: Halicek M; Little JV; Wang X; Chen ZG; Patel M; Griffith CC; El-Deiry MW; Saba NF; Chen AY; Fei B
  • Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.
    Angew Chem Int Ed Engl Volume: 56 Page(s): 16023 - 16027
    12/11/2017 Authors: Rahman MA; Wang P; Zhao Z; Wang D; Nannapaneni S; Zhang C; Chen Z; Griffith CC; Hurwitz SJ; Chen ZG
  • Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck Volume: 39 Page(s): 2433 - 2443
    12/01/2017 Authors: Zhang H; Kim S; Chen Z; Nannapaneni S; Chen AY; Moore CE; Sica G; Mosunjac M; Nguyen MLT; D'Souza G
  • Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status.
    Oncotarget Volume: 8 Page(s): 59008 - 59022
    08/29/2017 Authors: Zhang J; Nannapaneni S; Wang D; Liu F; Wang X; Jin R; Liu X; Rahman MA; Peng X; Qian G
  • Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.
    Oncogene Volume: 36 Page(s): 3797 - 3806
    07/06/2017 Authors: Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR
  • Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell LungCancer.
    Clin Lung Cancer Volume: 18 Page(s): e203 - e210
    05/01/2017 Authors: Saba NF; Wang Y; Fu H; Koenig L; Khuri FR; Shin DM; Chen ZG
  • Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice.
    Proc Natl Acad Sci U S A Volume: 114 Page(s): E3110 - E3118
    04/11/2017 Authors: Ali MRK; Rahman MA; Wu Y; Han T; Peng X; Mackey MA; Wang D; Shin HJ; Chen ZG; Xiao H
  • In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance.
    Mol Cancer Ther Volume: 16 Page(s): 729 - 738
    04/01/2017 Authors: Anisuzzaman ASM; Haque A; Wang D; Rahman MA; Zhang C; Chen Z; Chen ZG; Shin DM; Amin ARMR
  • Multiple biological functions of Twist1 in various cancers.
    Oncotarget Volume: 8 Page(s): 20380 - 20393
    03/21/2017 Authors: Zhao Z; Rahman MA; Chen ZG; Shin DM
  • Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
    J Nucl Med Volume: 58 Page(s): 412 - 418
    03/01/2017 Authors: Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
  • HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
    Clin Cancer Res Volume: 23 Page(s): 677 - 686
    02/01/2017 Authors: Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin ARMR; Rossi M; Patel M; El-Deiry M; Wadsworth JT
  • Deep Learning based Classification for Head and Neck Cancer Detection with Hyperspectral Imaging in an Animal Model.
    Proc SPIE Int Soc Opt Eng Volume: 10137
    02/01/2017 Authors: Ma L; Lu G; Wang D; Wang X; Chen ZG; Muller S; Chen A; Fei B
  • Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
    Bone Marrow Transplant Volume: 52 Page(s): 132 - 134
    01/01/2017 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Al-Kadhimi Z; Cohen JB; Flowers CR
  • Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic Profile.
    PLoS One Volume: 12 Page(s): e0170187
    01/01/2017 Authors: Chen Z; Li Z; Zhuang R; Yuan Y; Kutner M; Owonikoko T; Curran WJ; Kowalski J
  • RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis.
    Oncogene Volume: 35 Page(s): 5412 - 5421
    10/13/2016 Authors: Alesi GN; Jin L; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Kang S
  • Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation.
    Eur J Cancer Volume: 65 Page(s): 21 - 32
    09/01/2016 Authors: Qian G; Wang D; Magliocca KR; Hu Z; Nannapaneni S; Kim S; Chen Z; Sun S-Y; Shin DM; Saba NF
  • Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
    Oncotarget Volume: 7 Page(s): 44676 - 44685
    07/12/2016 Authors: Hu Z; Qian G; Mller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H
  • A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular -catenin expression.
    J Oral Pathol Med Volume: 45 Page(s): 399 - 408
    07/01/2016 Authors: Qian G; Hu Z; Xu H; Mller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM
  • Anticancer activity of drug conjugates in head and neck cancer cells.
    Front Biosci (Elite Ed) Volume: 8 Page(s): 358 - 369
    06/01/2016 Authors: Majumdar D; Rahman MA; Chen ZG; Shin DM
  • Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
    J Transl Med Volume: 14 Page(s): 111
    05/03/2016 Authors: Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R
  • Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome.
    Cancer Res Treat Volume: 48 Page(s): 596 - 604
    04/01/2016 Authors: Shaib W; Krishna K; Kim S; Goodman M; Rock J; Chen Z; Brutcher E; Staley CI; Maithel SK; Abdel-Missih S
  • A Minimum Spanning Forest-Based Method for Noninvasive Cancer Detection With Hyperspectral Imaging.
    IEEE Trans Biomed Eng Volume: 63 Page(s): 653 - 663
    03/01/2016 Authors: Pike R; Lu G; Wang D; Chen ZG; Fei B
  • Superpixel-based spectral classification for the detection of head and neck cancer with hyperspectral imaging.
    Volume: 9788
    02/27/2016 Authors: Chung H; Lu G; Tian Z; Wang D; Chen ZG; Fei B
  • Hyperspectral Imaging of Neoplastic Progression in a Mouse Model of Oral Carcinogenesis.
    Volume: 9788
    02/27/2016 Authors: Lu G; Qin X; Wang D; Muller S; Zhang H; Chen A; Chen ZG; Fei B
  • Quantitative Diagnosis of Tongue Cancer from Histological Images in an Animal Model.
    Proc SPIE Int Soc Opt Eng Volume: 9791
    02/27/2016 Authors: Lu G; Qin X; Wang D; Muller S; Zhang H; Chen A; Chen ZG; Fei B
  • Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.
    Cancer Prev Res (Phila) Volume: 9 Page(s): 63 - 73
    01/01/2016 Authors: Anisuzzaman ASM; Haque A; Rahman MA; Wang D; Fuchs JR; Hurwitz S; Liu Y; Sica G; Khuri FR; Chen ZG
  • Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.
    PLoS One Volume: 11 Page(s): e0168450
    01/01/2016 Authors: Wang D; Peng S; Amin ARMR; Rahman MA; Nannapaneni S; Liu Y; Shin DM; Saba NF; Eichler JF; Chen ZG
  • Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.
    Semin Cancer Biol Volume: 35 Suppl Page(s): S55 - S77
    12/01/2015 Authors: Amin ARMR; Karpowicz PA; Carey TE; Arbiser J; Nahta R; Chen ZG; Dong J-T; Kucuk O; Khan GN; Huang GS
  • Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling.
    Oncotarget Volume: 6 Page(s): 41324 - 41338
    12/01/2015 Authors: Oh Y-T; Yue P; Wang D; Tong J-S; Chen ZG; Khuri FR; Sun S-Y
  • Designing a broad-spectrum integrative approach for cancer prevention and treatment.
    Semin Cancer Biol Volume: 35 Suppl Page(s): S276 - S304
    12/01/2015 Authors: Block KI; Gyllenhaal C; Lowe L; Amedei A; Amin ARMR; Amin A; Aquilano K; Arbiser J; Arreola A; Arzumanyan A
  • Targeting HER (ERBB) signaling in head and neck cancer: An essential update.
    Mol Aspects Med Volume: 45 Page(s): 74 - 86
    11/01/2015 Authors: Zhang J; Saba NF; Chen GZ; Shin DM
  • HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.
    Carcinogenesis Volume: 36 Page(s): 1397 - 1406
    11/01/2015 Authors: Marullo R; Werner E; Zhang H; Chen GZ; Shin DM; Doetsch PW
  • 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nat Cell Biol Volume: 17 Page(s): 1484 - 1496
    11/01/2015 Authors: Lin R; Elf S; Shan C; Kang H-B; Ji Q; Zhou L; Hitosugi T; Zhang L; Zhang S; Seo JH
  • Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Cancer Volume: 121 Page(s): 3600 - 3611
    10/15/2015 Authors: Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR
  • FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.
    Cancer Lett Volume: 363 Page(s): 166 - 175
    07/28/2015 Authors: Haque A; Rahman MA; Fuchs JR; Chen ZG; Khuri FR; Shin DM; Amin ARMR
  • Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2.
    Apoptosis Volume: 20 Page(s): 986 - 995
    07/01/2015 Authors: Haque A; Rahman MA; Chen ZG; Saba NF; Khuri FR; Shin DM; Ruhul Amin ARM
  • Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.
    Cancer Cell Volume: 27 Page(s): 852 - 863
    06/08/2015 Authors: Han B; Park D; Li R; Xie M; Owonikoko TK; Zhang G; Sica GL; Ding C; Zhou J; Magis AT
  • Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle.
    Head Neck Pathol Volume: 9 Page(s): 223 - 235
    06/01/2015 Authors: Saba NF; Wilson M; Doho G; DaSilva J; Benjamin Isett R; Newman S; Chen ZG; Magliocca K; Rossi MR
  • Landscape of genetic alterations in non-smoking patients with oral tongue carcinoma: An analysis of The Cancer Genome Atlas (TCGA) head and neck squamous cell carcinoma data
    Volume: 33
    05/20/2015 Authors: Saba NF; Newman S; Rossi MR; Steuer CE; Zhang H; Patel M; Wadsworth JT; El-Deiry M; Magliocca KR; Owonikoko TK
  • Dual targeting of EGFR and HER3 with cetuximab and MM-121/SAR256212 in HNSCC patient derived xenograft (PDX) models.
    Volume: 33
    05/20/2015 Authors: Saba NF; Wang D; Qian G; Zhang H; Patel M; El-Deiry M; Wadsworth JT; Magliocca KR; Nannapaneni S; Shin DM
  • Estimation of Tissue Optical Parameters with Hyperspectral Imaging and Spectral Unmixing.
    Volume: 9417
    03/17/2015 Authors: Lu G; Qin X; Wang D; Chen ZG; Fei B
  • Quantitative Wavelength Analysis and Image Classification for Intraoperative Cancer Diagnosis with Hyperspectral Imaging.
    Volume: 9415
    02/21/2015 Authors: Lu G; Qin X; Wang D; Chen ZG; Fei B
  • Human papillomavirus 16 oncoprotein regulates the translocation of -catenin via the activation of epidermal growth factor receptor.
    Cancer Volume: 121 Page(s): 214 - 225
    01/15/2015 Authors: Hu Z; Mller S; Qian G; Xu J; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Saba NF
  • Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways.
    PLoS One Volume: 10 Page(s): e0124218
    01/01/2015 Authors: Amin ARMR; Haque A; Rahman MA; Chen ZG; Khuri FR; Shin DM
  • Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
    Cancer Chemother Pharmacol Volume: 74 Page(s): 1015 - 1022
    11/01/2014 Authors: Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R
  • RSK2-mediated phosphorylation of stathmin promotes microtubule polymerization, providing a pro-invasive advantage to metastatic cancer cells
    Volume: 74
    10/01/2014 Authors: Alesi G; Li D; Jin L; Chen GZ; Shin DM; Khuri F; Kang S
  • Potent curcumin analog FLLL-12 targets both intrinsic and extrinsic signaling pathways to induce apoptosis in lung cancers
    Volume: 74
    10/01/2014 Authors: Amin ARMR; Haque A; Rahman MA; Fuchs JR; Chen ZG; Shin DM
  • Ribonucleotide reductase subunit M2 plays important role in cisplatin resistance of cancer cells
    Volume: 74
    10/01/2014 Authors: Rahman MA; Amin ARMR; Peng X; Zhang J; Chen ZG; Shin DM
  • Combination of erlotinib and epigallocatechin-3-gallate induces apoptosis of squamous cell carcinoma of the head and neck through posttranslational regulation of Bim and Bcl-2
    Volume: 74
    10/01/2014 Authors: Haque A; Rahman MA; Chen ZG; Shin DM; Amin ARMR
  • EGFR targeted iron-oxide nanoparticles for photodynamic therapy in head and neck cancer
    Volume: 74
    10/01/2014 Authors: Wang D; Qin X; Qian G; Halig L; Fei B; Chen Z; Chen ZG; Saba NF; Shin DM; Xu H
  • Evaluation prognostic significance of circulating tumor cells (CTCs) using multiplexed gold nanoparticles in patients with head and neck cancer
    Volume: 74
    10/01/2014 Authors: Wang X; Qian X; Beitler JJ; Zhang J; Kang H; Chen ZG; Magliocca KR; Wang X; Chen Z; Nie S
  • Enhancing specificity in predication of human papillomavirus associated oropharyngeal squamous cell carcinoma by combining biomarkers p16 and beta-catenin
    Volume: 74
    10/01/2014 Authors: Qian G; Xu H; Hu Z; Kim S; Wang D; Zhang H; Chen Z; Muller S; Saba N; Shin DM
  • Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.
    Mol Cell Volume: 55 Page(s): 552 - 565
    08/21/2014 Authors: Shan C; Elf S; Ji Q; Kang H-B; Zhou L; Hitosugi T; Jin L; Lin R; Zhang L; Seo JH
  • Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer.
    ACS Nano Volume: 8 Page(s): 6620 - 6632
    07/22/2014 Authors: Wang D; Fei B; Halig LV; Qin X; Hu Z; Xu H; Wang YA; Chen Z; Kim S; Shin DM
  • Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma.
    Mol Cancer Ther Volume: 13 Page(s): 1826 - 1836
    07/01/2014 Authors: Jiang N; Wang D; Hu Z; Shin HJC; Qian G; Rahman MA; Zhang H; Amin ARMR; Nannapaneni S; Wang X
  • Predictive value of gene expression signatures in premalignant lesions of the head and neck for response to cheinoprevention with EGFR and COX-2 inhibitors.
    Volume: 32
    05/20/2014 Authors: Saba NF; Rossi MR; Dwivedi B; Switchenko JM; Magllocca KR; Ramalingam SS; Owonlkoko TK; Khuri FR; Chen ZG; Kowalski J
  • Expressions of EGFR, HER2, and HER3 and their correlations with clinical characteristics in oropharyngeal squamous cell carcinoma (OPSCC).
    Volume: 32
    05/20/2014 Authors: Saba NF; Qian G; Ning J; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG
  • Phenformin combines with selumetinib in targeting KRAS mutant non-small cell lung cancer cells with alternative LKB1 status.
    Volume: 32
    05/20/2014 Authors: Zhang J; Wang D; Qian G; Liu F; Rahman MA; Nannapaneni S; Wang X; Peng X; Chen ZG; Wong K-K
  • Transcriptional profiling of Tu212 cell line treated with EGCG and resveratrol to identify actionable targets for adjuvant therapy
    Volume: 32
    05/20/2014 Authors: Shin DM; Dwivedi B; Amin RARM; Haque AM; Saba NF; Rossl MR; Chen ZG; Kowalski J
  • Spectral-Spatial Classification Using Tensor Modeling for Cancer Detection with Hyperspectral Imaging.
    Volume: 9034 Page(s): 903413
    03/21/2014 Authors: Lu G; Halig L; Wang D; Chen ZG; Fei B
  • A Minimum Spanning Forest Based Hyperspectral Image Classification Method for Cancerous Tissue Detection.
    Volume: 9034 Page(s): 90341W
    03/21/2014 Authors: Pike R; Patton SK; Lu G; Halig LV; Wang D; Chen ZG; Fei B
  • Hyperspectral Imaging for Cancer Surgical Margin Delineation: Registration of Hyperspectral and Histological Images.
    Volume: 9036 Page(s): 90360S
    03/12/2014 Authors: Lu G; Halig L; Wang D; Chen ZG; Fei B
  • Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
    Cancer Prev Res (Phila) Volume: 7 Page(s): 283 - 291
    03/01/2014 Authors: Saba NF; Hurwitz SJ; Kono SA; Yang CS; Zhao Y; Chen Z; Sica G; Mller S; Moreno-Williams R; Lewis M
  • Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck.
    Head Neck Pathol Volume: 8 Page(s): 66 - 72
    03/01/2014 Authors: Saba NF; Magliocca KR; Kim S; Muller S; Chen Z; Owonikoko TK; Sarlis NJ; Eggers C; Phelan V; Grist WJ
  • OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.
    Cell Death Dis Volume: 5 Page(s): e1024
    01/23/2014 Authors: Ng WL; Chen G; Wang M; Wang H; Story M; Shay JW; Zhang X; Wang J; Amin ARMR; Hu B
  • Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.
    Cancer Prev Res (Phila) Volume: 7 Page(s): 65 - 73
    01/01/2014 Authors: Majumdar D; Jung K-H; Zhang H; Nannapaneni S; Wang X; Amin ARMR; Chen Z; Chen ZG; Shin DM
  • Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
    Curr Cancer Drug Targets Volume: 14 Page(s): 380 - 393
    01/01/2014 Authors: Zhu S; Moore TW; Morii N; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G
  • Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
    PLoS One Volume: 9 Page(s): e86369
    01/01/2014 Authors: Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin ARMR; Bonner M; Shin HJC
  • Spectral-spatial classification for noninvasive cancer detection using hyperspectral imaging.
    J Biomed Opt Volume: 19 Page(s): 106004
    01/01/2014 Authors: Lu G; Halig L; Wang D; Qin X; Chen ZG; Fei B
  • Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
    J Inorg Biochem Volume: 128 Page(s): 68 - 76
    11/01/2013 Authors: Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
  • Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.
    Mol Cancer Ther Volume: 12 Page(s): 2200 - 2212
    10/01/2013 Authors: Li R; Hu Z; Sun S-Y; Chen ZG; Owonikoko TK; Sica GL; Ramalingam SS; Curran WJ; Khuri FR; Deng X
  • Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions.
    Mol Imaging Biol Volume: 15 Page(s): 633 - 643
    10/01/2013 Authors: Amzat R; Taleghani P; Miller DL; Beitler JJ; Bellamy LM; Nye JA; Yu W; Savir-Baruch B; Osunkoya AO; Chen Z
  • NOX-Mediated Chronic Oxidative Stress Contributes to Genomic Instability and Radiosensitivity in Human Papillomavirus-Infected Head and Neck Cancer Cells.
    Volume: 54 Page(s): S31 - S31
    09/01/2013 Authors: Marullo R; Zhang H; Chen GZ; Shin DM; Doetsch PW
  • Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma.
    Head Neck Volume: 35 Page(s): 1007 - 1014
    07/01/2013 Authors: Sun X; Li J; Sica G; Fan S-Q; Wang Y; Chen Z; Muller S; Chen ZG; Fu X; Dong X-Y
  • RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
    Clin Cancer Res Volume: 19 Page(s): 3416 - 3428
    07/01/2013 Authors: Rahman MA; Amin ARMR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG
  • p90 RSK2 mediates antianoikis signals by both transcription-dependent and -independent mechanisms.
    Mol Cell Biol Volume: 33 Page(s): 2574 - 2585
    07/01/2013 Authors: Jin L; Li D; Lee JS; Elf S; Alesi GN; Fan J; Kang H-B; Wang D; Fu H; Taunton J
  • New perspectives of curcumin in cancer prevention.
    Cancer Prev Res (Phila) Volume: 6 Page(s): 387 - 400
    05/01/2013 Authors: Park W; Amin ARMR; Chen ZG; Shin DM
  • Combined treatment with HER3 antibody MM-121/SAR 256212 and EGFR antibody cetuximab in pre-clinical models of head and neck cancer.
    Volume: 73
    04/15/2013 Authors: Jiang N; Wang D; Hu Z; Rahman AM; Zhang H; Amin RA; Wang X; Chen Z; Dong SM; Garcia G
  • Subceliular translocation of beta-catenin and its relationship with EGFR activation in HPV16 positive OPSCC
    Volume: 73
    04/15/2013 Authors: Hu Z; Jiang N; Muller S; Saba N; Wang D; Zhang H; Shin DM; Chen ZG
  • Role of ribonucleotide reductase subunit M2 in regulation of head and neck and lung cancer undergoing invasion.
    Volume: 73
    04/15/2013 Authors: Rahman MA; Amin ARMR; Nannapaneni S; Hu Z; Kang H; Chen ZG; Shin DM
  • Folate receptor targeted iron oxide nanoparticles loaded with cisplatin for imaging and therapy in head and neck squamous cell carcinoma (HNSCC)
    Volume: 73
    04/15/2013 Authors: Kang H; Huang J; Peng X; Chen ZG; Mao H; Shin DM
  • Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma.
    Cancer Biol Ther Volume: 14 Page(s): 365 - 369
    04/01/2013 Authors: Fan S; Mller S; Chen ZG; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun S-Y
  • Biodistribution Study of Nanoparticle Encapsulated Photodynamic Therapy Drugs Using Multispectral Imaging.
    Proc SPIE Int Soc Opt Eng Volume: 8672
    03/29/2013 Authors: Halig LV; Wang D; Wang AY; Chen ZG; Fei B
  • Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer.
    J Thorac Oncol Volume: 8 Page(s): 369 - 372
    03/01/2013 Authors: Ramalingam SS; Owonikoko TK; Behera M; Subramanian J; Saba NF; Kono SA; Gal AA; Sica G; Harvey RD; Chen Z
  • Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
    Clin Cancer Res Volume: 19 Page(s): 1244 - 1256
    03/01/2013 Authors: Shin DM; Zhang H; Saba NF; Chen AY; Nannapaneni S; Amin ARMR; Mller S; Lewis M; Sica G; Kono S
  • Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
    PLoS One Volume: 8 Page(s): e74670
    01/01/2013 Authors: Li R; You S; Hu Z; Chen ZG; Sica GL; Khuri FR; Curran WJ; Shin DM; Deng X
  • Lessons learned from 118,970 multidetector computed tomographic intravenous contrast material administrations: impact of catheter dwell time and gauge, catheter location, rate of contrast material administration, and patient age and sex on volume of extravasate.
    J Comput Assist Tomogr Volume: 37 Page(s): 286 - 288
    01/01/2013 Authors: Moreno CC; Pinho D; Nelson RC; Sahani DV; Jenkins M; Zabrycki M; Chaudhry H; Kang J; Chen Z
  • The pivotal role of integrin 1 in metastasis of head and neck squamous cell carcinoma.
    Clin Cancer Res Volume: 18 Page(s): 4589 - 4599
    09/01/2012 Authors: Wang D; Mller S; Amin ARMR; Huang D; Su L; Hu Z; Rahman MA; Nannapaneni S; Koenig L; Chen Z
  • A Systematic Analysis Of High-dose Radiation In The Treatment Of Surgically Unresectable, Locally Advanced Non-small Cell Lung Cancer.
    JOURNAL OF THORACIC ONCOLOGY Volume: 7 Page(s): S212 - S213
    09/01/2012 Authors: Behera M; Beitler JJ; Bhimani C; Higgins K; Chen Z; Deng X; Curran WJ; Khuri FR; Ramalingam SS; Owonikoko TK
  • A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
    Int J Cancer Volume: 131 Page(s): 956 - 969
    08/15/2012 Authors: Zhang H; Yun S; Batuwangala TD; Steward M; Holmes SD; Pan L; Tighiouart M; Shin HJC; Koenig L; Park W
  • Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
    Eur J Cancer Volume: 48 Page(s): 1682 - 1691
    07/01/2012 Authors: Xu J; Mller S; Nannapaneni S; Pan L; Wang Y; Peng X; Wang D; Tighiouart M; Chen Z; Saba NF
  • Hyperspectral imaging and quantitative analysis for prostate cancer detection.
    J Biomed Opt Volume: 17 Page(s): 076005
    07/01/2012 Authors: Akbari H; Halig LV; Schuster DM; Osunkoya A; Master V; Nieh PT; Chen GZ; Fei B
  • Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.
    Integr Biol (Camb) Volume: 4 Page(s): 633 - 640
    06/01/2012 Authors: Zhu S; Moore TW; Lin X; Morii N; Mancini A; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ
  • Increased expression of Rab coupling protein in squamous cell carcinoma of the head and neck and its clinical significance.
    Oncol Lett Volume: 3 Page(s): 1231 - 1236
    06/01/2012 Authors: Dai Y; Liu Y; Huang D; Yu C; Cai G; Pi L; Ren C; Chen GZ; Tian Y; Zhang X
  • Behavior of circulating tumor cells detected by EGF tagged SERS nanoparticles in head and neck cancer patients
    Volume: 30
    05/20/2012 Authors: Beitler JJ; Wang X; Qian X; Wang H; Chen ZG; Khuri FR; Nie S; Shin DM
  • Folate-targeted iron oxide nanoparticles loaded with cisplatin for imaging and therapy in head and neck squamous cell carcinoma (HNSCC)
    Volume: 30
    05/20/2012 Authors: Kang H; Huang J; Mao H; Chen ZG; Peng X; Shin DM
  • Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.
    J Control Release Volume: 159 Page(s): 384 - 392
    05/10/2012 Authors: Rahman MA; Amin ARMR; Wang X; Zuckerman JE; Choi CHJ; Zhou B; Wang D; Nannapaneni S; Koenig L; Chen Z
  • Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
    Cancer Chemother Pharmacol Volume: 69 Page(s): 577 - 590
    03/01/2012 Authors: Hurwitz SJ; Zhang H; Yun S; Batuwangala TD; Steward M; Holmes SD; Rycroft D; Pan L; Tighiouart M; Shin HJC
  • Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer.
    Cancer Biol Ther Volume: 13 Page(s): 272 - 280
    03/01/2012 Authors: Li Y; Fan S; Koo J; Yue P; Chen ZG; Owonikoko TK; Ramalingam SS; Khuri FR; Sun S-Y
  • Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line's supernatant via nuclear factor B/Rel pathway.
    Chin J Integr Med Volume: 18 Page(s): 203 - 208
    03/01/2012 Authors: Chen Z; Yu B; Wu X-L; Dai C-Q; Qian G-Q; Yu J-Z; He H-B; Wang Z-X; Hou J; Chen X-Y
  • Advances in Targeting HER3 as an Anticancer Therapy.
    Chemother Res Pract Volume: 2012 Page(s): 817304
    01/01/2012 Authors: Jiang N; Saba NF; Chen ZG
  • Detection of Cancer Metastasis Using a Novel Macroscopic Hyperspectral Method.
    Proc SPIE Int Soc Opt Eng Volume: 8317 Page(s): 831711
    01/01/2012 Authors: Akbari H; Halig LV; Zhang H; Wang D; Chen ZG; Fei B
  • Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models.
    Theranostics Volume: 2 Page(s): 113 - 121
    01/01/2012 Authors: Zhao Q; Wang L; Cheng R; Mao L; Arnold RD; Howerth EW; Chen ZG; Platt S
  • Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.
    ACS Nano Volume: 5 Page(s): 9480 - 9493
    12/27/2011 Authors: Peng X-H; Wang Y; Huang D; Wang Y; Shin HJ; Chen Z; Spewak MB; Mao H; Wang X; Wang Y
  • Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.
    Mol Cell Biol Volume: 31 Page(s): 4938 - 4950
    12/01/2011 Authors: Fan J; Hitosugi T; Chung T-W; Xie J; Ge Q; Gu T-L; Polakiewicz RD; Chen GZ; Boggon TJ; Lonial S
  • Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis.
    Head Neck Volume: 33 Page(s): 1501 - 1512
    10/01/2011 Authors: Kline ER; Muller S; Pan L; Tighiouart M; Chen ZG; Marcus AI
  • Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia.
    Clin Lymphoma Myeloma Leuk Volume: 11 Page(s): 427 - 432
    10/01/2011 Authors: Arellano M; Bernal-Mizrachi L; Pan L; Tighiouart M; Souza L; Guo X; McLemore M; Lima L; Sunay S; Heffner LT
  • Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR.
    Mol Cancer Volume: 10 Page(s): 116
    09/22/2011 Authors: Wang D; Su L; Huang D; Zhang H; Shin DM; Chen ZG
  • Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.
    Cancer Res Volume: 71 Page(s): 1526 - 1532
    03/01/2011 Authors: Wang X; Qian X; Beitler JJ; Chen ZG; Khuri FR; Lewis MM; Shin HJC; Nie S; Shin DM
  • Application of nanoparticle quantum dot as a unique tool for identification of high risk cancer cells for metastasis
    CLINICAL & EXPERIMENTAL METASTASIS Volume: 28 Page(s): 191 - 191
    02/01/2011 Authors: Xu J; Huang D; Wang Y; Hoyt CC; Peng X; Wang D; Zhang H; Shin DM; Chen ZG
  • c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL.
    Mol Cancer Volume: 9 Page(s): 315
    12/20/2010 Authors: Fu L; Lin Y-D; Elrod HA; Yue P; Oh Y; Li B; Tao H; Chen GZ; Shin DM; Khuri FR
  • Therapeutic Nanoparticles as Controlled Anti-Cancer Medications.
    Curr Cancer Drug Targets
    12/15/2010 Authors: Chen GZ
  • Small-molecule delivery by nanoparticles for anticancer therapy.
    Trends Mol Med Volume: 16 Page(s): 594 - 602
    12/01/2010 Authors: Chen ZG
  • Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
    J Biol Chem Volume: 285 Page(s): 34557 - 34565
    11/05/2010 Authors: Amin ARMR; Wang D; Zhang H; Peng S; Shin HJC; Brandes JC; Tighiouart M; Khuri FR; Chen ZG; Shin DM
  • Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact.
    PLoS One Volume: 5 Page(s): e12178
    08/16/2010 Authors: Elrod HA; Fan S; Muller S; Chen GZ; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun S-Y
  • Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling.
    PLoS One Volume: 5 Page(s): e11456
    07/06/2010 Authors: Song J; Chang I; Chen Z; Kang M; Wang C-Y
  • Chemoprevention with erlotinib and celecoxib in advanced premalignant lesions of the head and neck: Results of a phase I study
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Saba NF; Muller S; Chen AY; Grist W; Gibson K; Nannapaneni S; Yang CS; Khuri FR; Chen ZG; Shin DM
  • Evaluation of ALDH1-A1 as a biomarker for metastasis of head and neck cancer
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Chen ZG; Nannapaneni S; Muller S; Saba NF; Tighiouart M; Pan L; Shin DM
  • Targeted delivery of paclitaxel to tumor cells: synthesis and in vitro evaluation.
    J Med Chem Volume: 53 Page(s): 3127 - 3132
    04/22/2010 Authors: Ndungu JM; Lu YJ; Zhu S; Yang C; Wang X; Chen G; Shin DM; Snyder JP; Shoji M; Sun A
  • p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.
    J Clin Invest Volume: 120 Page(s): 1165 - 1177
    04/01/2010 Authors: Kang S; Elf S; Lythgoe K; Hitosugi T; Taunton J; Zhou W; Xiong L; Wang D; Muller S; Fan S
  • Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.
    Sci Signal Volume: 2 Page(s): ra73
    11/17/2009 Authors: Hitosugi T; Kang S; Vander Heiden MG; Chung T-W; Elf S; Lythgoe K; Dong S; Lonial S; Wang X; Chen GZ
  • HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.
    ACS Nano Volume: 3 Page(s): 3165 - 3174
    10/27/2009 Authors: Wang X; Li J; Wang Y; Cho KJ; Kim G; Gjyrezi A; Koenig L; Giannakakou P; Shin HJC; Tighiouart M
  • Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer.
    Head Neck Volume: 31 Page(s): 1263 - 1273
    10/01/2009 Authors: Klass CM; Choe MS; Hurwitz SJ; Tighiouart M; Zhang X; Chen ZG; Shin DM
  • Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
    Cancer Prev Res (Phila) Volume: 2 Page(s): 823 - 829
    09/01/2009 Authors: Saba NF; Choi M; Muller S; Shin HJC; Tighiouart M; Papadimitrakopoulou VA; El-Naggar AK; Khuri FR; Chen ZG; Shin DM
  • PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.
    Oncogene Volume: 28 Page(s): 2348 - 2357
    06/18/2009 Authors: Sun Q; Ming L; Thomas SM; Wang Y; Chen ZG; Ferris RL; Grandis JR; Zhang L; Yu J
  • Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
    Nanotechnology Volume: 20 Page(s): 225102
    06/03/2009 Authors: Huang D-H; Su L; Peng X-H; Zhang H; Khuri FR; Shin DM; Chen ZG
  • Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
    Cancer Prev Res (Phila) Volume: 2 Page(s): 538 - 545
    06/01/2009 Authors: Amin ARMR; Khuri FR; Chen ZG; Shin DM
  • Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.
    Head Neck Volume: 31 Page(s): 475 - 481
    04/01/2009 Authors: Saba NF; Wang X; Mller S; Tighiouart M; Cho K; Nie S; Chen Z; Shin DM
  • Advances of cancer therapy by nanotechnology.
    Cancer Res Treat Volume: 41 Page(s): 1 - 11
    03/01/2009 Authors: Wang X; Wang Y; Chen ZG; Shin DM
  • Increased ALDH1 Expression in Squamous Cell Carcinoma of the Head and Neck May Be a Predictor for Lymph Node Metastases
    Volume: 89 Page(s): 250A - 250A
    01/01/2009 Authors: Muller S; Chen ZG; Nannapaneni S; Shin DM
  • Increased ALDH1 Expression in Squamous Cell Carcinoma of the Head and Neck May Be a Predictor for Lymph Node Metastases
    Volume: 22 Page(s): 250A - 250A
    01/01/2009 Authors: Muller S; Chen ZG; Nannapaneni S; Shin DM
  • Distinct growth factor-induced dynamic mass redistribution (DMR) profiles for monitoring oncogenic signaling pathways in various cancer cells.
    J Recept Signal Transduct Res Volume: 29 Page(s): 182 - 194
    01/01/2009 Authors: Du Y; Li Z; Li L; Chen ZG; Sun S-Y; Chen P; Shin DM; Khuri FR; Fu H
  • The cancer stem cell concept in progression of head and neck cancer.
    J Oncol Volume: 2009 Page(s): 894064
    01/01/2009 Authors: Chen ZG
  • Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma.
    Br J Cancer Volume: 99 Page(s): 1684 - 1694
    11/18/2008 Authors: Zhang H; Su L; Mller S; Tighiouart M; Xu Z; Zhang X; Shin HJC; Hunt J; Sun S-Y; Shin DM
  • Effective combination of green tea EGCG and EGFR-TKI erlotinib for chemoprevention and therapy in head and neck cancer
    Volume: 6 Page(s): 38 - 38
    10/01/2008 Authors: Shin DM; Amin ARM; Zhang X; Chen ZG; Khuri FR
  • Using spiral intensity profile to quantify head and neck cancer.
    Volume: 2008
    10/01/2008 Authors: Kong KY; Shanna Y; Raza SH; Chen ZG; Muller S; Wang MD
  • Nanoparticle therapeutics: an emerging treatment modality for cancer.
    Nat Rev Drug Discov Volume: 7 Page(s): 771 - 782
    09/01/2008 Authors: Davis ME; Chen ZG; Shin DM
  • Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
    Int J Cancer Volume: 123 Page(s): 1005 - 1014
    09/01/2008 Authors: Zhang X; Zhang H; Tighiouart M; Lee JE; Shin HJ; Khuri FR; Yang CS; Chen Z'G'; Shin DM
  • Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Cancer Volume: 113 Page(s): 97 - 107
    07/01/2008 Authors: Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen ZG
  • Therapeutic nanoparticles for drug delivery in cancer.
    Clin Cancer Res Volume: 14 Page(s): 1310 - 1316
    03/01/2008 Authors: Cho K; Wang X; Nie S; Chen ZG; Shin DM
  • PASuite: a preprocessing algorithm suite for cellular and molecular image classification in cancer diagnosis and treatment.
    Volume: 2008 Page(s): 3114 - 3117
    01/01/2008 Authors: Sharma Y; Raza SH; Kong KY; Chaudry Q; Muller S; Young AN; Chen ZG; Wang MD
  • Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
    Int J Nanomedicine Volume: 3 Page(s): 311 - 321
    01/01/2008 Authors: Peng X-H; Qian X; Mao H; Wang AY; Chen ZG; Nie S; Shin DM
  • Application of nanotechnology in cancer therapy and imaging.
    CA Cancer J Clin Volume: 58 Page(s): 97 - 110
    01/01/2008 Authors: Wang X; Yang L; Chen ZG; Shin DM
  • In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags.
    Nat Biotechnol Volume: 26 Page(s): 83 - 90
    01/01/2008 Authors: Qian X; Peng X-H; Ansari DO; Yin-Goen Q; Chen GZ; Shin DM; Yang L; Young AN; Wang MD; Nie S
  • Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer.
    Curr Cancer Drug Targets Volume: 7 Page(s): 613 - 622
    11/01/2007 Authors: Chen ZG
  • CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
    Cancer Res Volume: 67 Page(s): 7518 - 7524
    08/01/2007 Authors: Yoon Y; Liang Z; Zhang X; Choe M; Zhu A; Cho HT; Shin DM; Goodman MM; Chen ZG; Shim H
  • Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck.
    Clin Cancer Res Volume: 13 Page(s): 3015 - 3023
    05/15/2007 Authors: Choe MS; Chen Z; Klass CM; Zhang X; Shin DM
  • Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens.
    Infect Agent Cancer Volume: 2 Page(s): 8
    04/02/2007 Authors: Scheurer ME; Dillon LM; Chen Z; Follen M; Adler-Storthz K
  • Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.
    Head Neck Volume: 29 Page(s): 351 - 361
    04/01/2007 Authors: Zhang X; Chen ZG; Khuri FR; Shin DM
  • Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
    Head Neck Volume: 29 Page(s): 236 - 243
    03/01/2007 Authors: Zhang X; Hunt JL; Shin DM; Chen ZG
  • Exploring cancer stem cell-like feature and potential treatment of metastatic SCCHN
    CLINICAL & EXPERIMENTAL METASTASIS Volume: 24 Page(s): 278 - 278
    01/01/2007 Authors: Chen ZG; Shin DM; Su L; Zhang X; Yoon Y; Liang Z; Zhang H; Shim H
  • Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis.
    Clin Exp Metastasis Volume: 23 Page(s): 209 - 222
    01/01/2006 Authors: Zhang X; Su L; Pirani AA; Wu H; Zhang H; Shin DM; Gernert KM; Chen ZG
  • Correlation of cyclooxygenase-2 (COX-2) expression with tumor progression and survival in head and neck cancer (HNC)
    Volume: 14 Page(s): 2689S - 2689S
    11/01/2005 Authors: Klass C; Choe MS; Tighiouart M; Shin HJ; Rogatko A; Muller S; Papadimitrakopoulou VA; Khuri FR; Hong WK; Chen GZ
  • DNA microarray analysis in comparison of metastatic SCCHN with non-metastatic SCCHN reveals a feature of epithelial-mesenchymal transition
    Volume: 14 Page(s): 2690S - 2690S
    11/01/2005 Authors: Chen ZG; Wu HY; Zhang X; Su L; Pirani AA; Gernert KM; Shin DM
  • Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
    Clin Cancer Res Volume: 11 Page(s): 6261 - 6269
    09/01/2005 Authors: Zhang X; Chen ZG; Choe MS; Lin Y; Sun S-Y; Wieand HS; Shin HJC; Chen A; Khuri FR; Shin DM
  • Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer.
    Mol Cancer Ther Volume: 4 Page(s): 1448 - 1455
    09/01/2005 Authors: Choe MS; Zhang X; Shin HJC; Shin DM; Chen ZG
  • Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.
    Oncogene Volume: 24 Page(s): 5897 - 5904
    09/01/2005 Authors: Wang J; Zhang X; Thomas SM; Grandis JR; Wells A; Chen ZG; Ferris RL
  • Correlation of human papillomavirus type 16 and human papillomavirus type 18 e7 messenger RNA levels with degree of cervical dysplasia.
    Cancer Epidemiol Biomarkers Prev Volume: 14 Page(s): 1948 - 1952
    08/01/2005 Authors: Scheurer ME; Tortolero-Luna G; Guillaud M; Follen M; Chen Z; Dillon LM; Adler-Storthz K
  • Role of cyclooxygenase-2 (COX-2) expression in tumor progression and survival in the squamous cell carcinoma of the head and neck (HNSCC).
    Volume: 23 Page(s): 502S - 502S
    06/01/2005 Authors: Choe MS; Tighiouart M; Rogatko A; Muller S; Shin HJ; Francisco M; Papadimitrakopoulou VA; Khuri FR; Hong WK; Chen Z
  • GRIM-19 expression and its correlation with clinical outcomes of an induction chemotherapy for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Volume: 23 Page(s): 504S - 504S
    06/01/2005 Authors: Zhang X; Choe MS; Lee JE; Muller S; Tighiouart M; Rogatko A; Glisson BS; Chen Z; Khuri FR; Shin DM
  • Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
    Clin Cancer Res Volume: 10 Page(s): 8451 - 8459
    12/15/2004 Authors: Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
  • Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
    Clin Cancer Res Volume: 10 Page(s): 5930 - 5939
    09/01/2004 Authors: Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM
  • Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype.
    Cancer Res Volume: 64 Page(s): 1861 - 1866
    03/01/2004 Authors: Wang J; Xi L; Hunt JL; Gooding W; Whiteside TL; Chen Z; Godfrey TE; Ferris RL
  • Simultaneously targeting epidermal growth factor receptor (EGFR) and cycloxygenase-2 (COX-2) as a potential novel approach for chemoprevention of squamous cell carcinoma of the head and neck (SCCHN)
    Volume: 12 Page(s): 1318S - 1318S
    11/01/2003 Authors: Shin DM; Zhang X; Wang ZQ; Li MF; Grandis JR; Chen ZG
  • Expression of protease-activated receptor-1 (PAR-1): A differential marker for metastasis of squamous cell carcinoma of the head and neck (SCCHN)
    Volume: 12 Page(s): 1309S - 1309S
    11/01/2003 Authors: Zhang X; Hunt JL; Landsittel DP; Shin DM; Chen ZG
  • Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck.
    Cancer Lett Volume: 199 Page(s): 83 - 89
    09/10/2003 Authors: Arany I; Chen S-H; Megyesi JK; Adler-Storthz K; Chen Z; Rajaraman S; Ember IA; Tyring SK; Brysk MM
  • A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
    Cancer Volume: 95 Page(s): 1663 - 1672
    10/15/2002 Authors: Zhang X; Liu Y; Gilcrease MZ; Yuan XH; Clayman GL; Adler-Storthz K; Chen Z
  • An AP-1 binding site mutation in HPV-16 LCR enhances E6/E7 promoter activity in human oral epithelial cells.
    Virus Genes Volume: 24 Page(s): 29 - 37
    01/01/2002 Authors: Liu Y; Li JZ; Yuan XH; Adler-Storthz K; Che Z
  • Expression of protease-activated receptor 1 in oral squamous cell carcinoma.
    Cancer Lett Volume: 169 Page(s): 173 - 180
    08/28/2001 Authors: Liu Y; Gilcrease MZ; Henderson Y; Yuan XH; Clayman GL; Chen Z
  • A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards.
    Mol Cell Probes Volume: 14 Page(s): 127 - 135
    04/01/2000 Authors: Ke LD; Chen Z; Yung WK
  • Correlation of cisplatin sensitivity with differential alteration of EGFR expression in head and neck cancer cells.
    Anticancer Res Volume: 20 Page(s): 899 - 902
    01/01/2000 Authors: Chen Z; Ke LD; Yuan XH; Adler-Storthz K
  • Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines.
    Oral Oncol Volume: 35 Page(s): 415 - 420
    07/01/1999 Authors: Ke LD; Adler-Storthz K; Mitchell MF; Clayman GL; Chen Z
  • Zinc-alpha2-glycoprotein expression as a marker of differentiation in human oral tumors.
    Cancer Lett Volume: 137 Page(s): 117 - 120
    03/22/1999 Authors: Brysk MM; Lei G; Adler-Storthz K; Chen Z; Brysk H; Tyring SK; Arany I
  • Differentiation-dependent expression of growth regulatory cytokines and their receptors in squamous cell carcinomas of the head and neck.
    Anticancer Res Volume: 19 Page(s): 3623 - 3626
    01/01/1999 Authors: Arany I; Brysk MM; Chen Z; Adler-Storthz K; Tyring SK
  • Local inflammation may influence oral tumor cell differentiation.
    Anticancer Res Volume: 19 Page(s): 1065 - 1067
    01/01/1999 Authors: Arany I; Adler-Storthz K; Chen Z; Tyring SK; Brysk H; Lei G; Brysk MM
  • Differential expression of epidermal growth factor receptor in human head and neck cancers.
    Head Neck Volume: 20 Page(s): 320 - 327
    07/01/1998 Authors: Ke LD; Adler-Storthz K; Clayman GL; Yung AW; Chen Z
  • Tumor differentiation-dependent local immunity in human head and neck cancers.
    Cancer Lett Volume: 123 Page(s): 173 - 176
    01/30/1998 Authors: Arany I; Adler-Storthz K; Chen Z; Tyring SK; Brysk MM
  • Differentiation-dependent gene expression in head and neck cancers.
    JOURNAL OF DENTAL RESEARCH Volume: 77 Page(s): 109 - 109
    01/01/1998 Authors: Arany I; Adler-Storthz K; Chen Z; Tyring SK; Brysk H; Brysk M
  • Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences.
    Cancer Res Volume: 57 Page(s): 1614 - 1619
    04/15/1997 Authors: Chen Z; Storthz KA; Shillitoe EJ
  • Differentiation markers in oral carcinoma cell lines and tumors.
    Anticancer Res Volume: 17 Page(s): 4607 - 4610
    01/01/1997 Authors: Arany I; Adler-Storthz K; Chen Z; Tyring SK; Brysk H; Brysk MM
  • Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.
    Cancer Gene Ther Volume: 3 Page(s): 18 - 23
    01/01/1996 Authors: Chen Z; Kamath P; Zhang S; St John L; Adler-Storthz K; Shillitoe EJ
  • Effects of mutations in the human papillomavirus LCR cloned from oral cancer cell lines.
    JOURNAL OF DENTAL RESEARCH Volume: 75 Page(s): 1071 - 1071
    01/01/1996 Authors: Chen Z; Shillitoe EJ; AdlerStorthz K
  • Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18.
    Cancer Gene Ther Volume: 2 Page(s): 263 - 271
    12/01/1995 Authors: Chen Z; Kamath P; Zhang S; Weil MM; Shillitoe EJ
  • Adding a positive charge at residue 46 of Drosophila alcohol dehydrogenase increases cofactor specificity for NADP+.
    FEBS Lett Volume: 356 Page(s): 81 - 85
    12/12/1994 Authors: Chen Z; Tsigelny I; Lee WR; Baker ME; Chang SH
  • Papillomaviruses as targets for cancer gene therapy.
    Cancer Gene Ther Volume: 1 Page(s): 193 - 204
    09/01/1994 Authors: Shillitoe EJ; Kamath P; Chen Z
  • HAMMERHEAD RIBOZYMES AS POTENTIAL ANTIVIRAL AGENTS FOR HUMAN PAPILLOMA-VIRUS TYPE-18
    FASEB JOURNAL Volume: 8 Page(s): A1446 - A1446
    04/19/1994 Authors: CHEN Z; KAMATH P; SHILLITOE EJ
  • Sequence diversity in the 5' untranslated region of rabbit muscle phosphofructokinase mRNA.
    Biochem Biophys Res Commun Volume: 170 Page(s): 1056 - 1060
    08/16/1990 Authors: Li J; Chen Z; Lu L; Byrnes M; Chang SH
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements